Tumor pretargeting: Role of avidin/streptavidin on monoclonal antibody internalization

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1378-1381

  Casalini, Patrizia ^b   Luison, Elena ^b   Ménard, Sylvie ^b   Colnaghi, Maria I ^a   Paganelli, Giovanni ^b   Canevari, Silvana ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

Avidin; Cellular internalization; Monoclonal antibody; Streptavidin; Tumor pretargeting

Indexed keywords

AVIDIN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; INDIUM 111; MONOCLONAL ANTIBODY; STREPTAVIDIN;

ARTICLE; CANCER LOCALIZATION; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTERNALIZATION; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN TARGETING; RADIOISOTOPE DISTRIBUTION;

ANTIBODIES, MONOCLONAL; AVIDIN; BACTERIAL PROTEINS; BIOTIN; CARCINOEMBRYONIC ANTIGEN; CARRIER PROTEINS; COLONIC NEOPLASMS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; RADIOIMMUNODETECTION; RECEPTORS, CELL SURFACE; STREPTAVIDIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR CELLS, CULTURED;

EID: 0030883111     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Green NM. Avidin. Adv Protein Chem 1975;29:85-133.
2. Wilchek M, Bayer E. Avidin-biotin technology. Methods Enzymol 1990;184:5-45.
3. Green NM. Avidin and streptavidin. Methods Enzymol 1990;184:51-67.
4. Chilkoti A, Stayton PS. Molecular origins of the slow dissociation kinetics of the streptavidin-biotin complex. J Am Chem Soc 1995;117:10622-10628.
5. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
6. Paganelli G, Pervez S, Siccardi AG. Intraperitoneal radio-localization of tumors pretargeted by biotinylated monoclonal antibodies. Int J Cancer 1990;45:1184-1189.
7. Paganelli G, Magnani P, Zito F, et al. Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res 1991:51:5960-5966.
8. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992;33:1810-1815.
9. Kobayashi H, Sakahara H, Hosono M, et al. Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as a "chase" without decreased accumulation in the target tumor. J Nucl Med 1994;35:1677-1684.
10. Paganelli G, Stella M, Zito F, et al. Radioimmunoguided surgery using iodine-125-labeled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994;35:1970-1975.
11. Yao Z, Zhang M, Kobayashi H, et al. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J Nucl Med 1995;36:837-841.
12. Kalofonos HP, Rusckowski M, Siebecker DA, et al. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl Med 1990;31:1791-1796.
13. Stella M, De Nardi P, Paganelli G. Avidin-biotin system in radioimmunoguided surgery for colorectal cancer: advantages and limits. Dis Colon Rectum 1994;37:335-343.
14. Magnani P, Paganelli G, Modorati G, et al. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. J Nucl Med 1996;37:967-971.
15. Goldenberg DM, Larson SM, Reisfeld RA, Schlom J. Targeting cancer with radiolabeled antibodies. Immunol Today 1995;16:261-264.
16. Larson SM. Improving the balance between treatment and diagnosis: a role for radioimmunodetection. Cancer Res 1995;55(suppl):5756S-5758S.
17. Miotti S, Canevari S, Ménard S, et al. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 1987;39:297-303.
18. Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 1991;51:6125-6132.
19. Crippa F, Buraggi GL, Di Re E, et al. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer 1991;27:724-729.
20. 131I-MOv18: clinical results in patients with minimal residual disease of ovarian cancer. Eur J Cancer 1995:31A:686-690.
21. Paganelli G, Belloni C, Magnani P, et al. Two-step tumor targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med 1992;19:322-329.
22. Casalini P, Mezzanzanica D, Canevari S, et al. Use of combination of monoclonal antibodies directed against three distinct epitopes of a tumor-associated antigen: analysis of cell binding and internalization. Int J Cancer 1991;48:284-290.
23. Siccardi AG, Buraggi GL, Callegaro L, et al. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab′)2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study. Cancer Res 1989;49:3095-3103.
24. Matzku S, Bröcker E-B, Brüggen J, Dippold WG, Tilgen W. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines. Cancer Res 1986;46:3848-3854.
25. Li PY, Del Vecchio S, Fonti R, et al. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 1996;37:665-672.
26. Thompson JA. Molecular cloning and expression of carcinoembryonic antigen gene family members. Tumor Biol 1995;16:10-16.
27. Miotti S, Facheris P, Tomassetti A, et al. Growth of ovary carcinoma cell lines at physiological folate concentration: effect on folate binding protein expression in vitro and in vivo. Int J Cancer 1995;63:395-401.
28. Paganelli G, Magnani P, Siccardi AG. Clinical application of the avidin-biotin system for tumor targeting. In: Goldenberg DM, ed. Cancer therapy with radiolabeled antibodies. Boca Raton, FL: CRC Press; 1995:239-254.